[Interleukin-2 and staurosporine abolish inhibition of splenocyte nonspecific cytotoxicity caused by high doses of phorbol myristate acetate in rats].
Anisimov
A G
AG
Bolotnikov
I A
IA
D000818:Animals; D002455:Cell Division / Q000187:drug effects / Q000276:immunology; D002470:Cell Survival / Q000187:drug effects / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D019311:Staurosporine / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D004791:Enzyme Inhibitors; D007376:Interleukin-2; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate
Interleĭkin-2 i staurosporin otmeniaiut ingibirovanie nespetsificheskoĭ tsitotoksichnosti splenotsitov krys vysokimi dozami forbolmiristatatsetata.